Invivyd, Inc. (IVVD)
0.6034
+0.04
(+7.18%)
USD |
NASDAQ |
Nov 09, 13:59
Invivyd Max Drawdown (5Y) : 99.36% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 99.36% |
| September 30, 2026 | 99.36% |
| August 31, 2026 | 99.36% |
| July 31, 2026 | 99.36% |
| June 30, 2026 | 99.36% |
| May 31, 2026 | 99.36% |
| April 30, 2026 | 99.36% |
| Date | Value |
|---|---|
| March 31, 2026 | 99.36% |
| February 28, 2026 | 99.36% |
| January 31, 2026 | 99.36% |
| December 31, 2025 | 99.36% |
| November 30, 2025 | 99.36% |
| October 31, 2025 | 99.36% |
| September 30, 2025 | 99.36% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Lineage Cell Therapeutics, Inc. | 87.55% |
| Armata Pharmaceuticals, Inc. | 97.66% |
| Voyager Therapeutics, Inc. | 91.54% |
| Black Diamond Therapeutics, Inc. | 97.21% |
| Elicio Therapeutics, Inc. | 98.72% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -68.03 |
| Beta (5Y) | 1.201 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 158.3% |
| Historical Sharpe Ratio (5Y) | -0.3676 |
| Historical Sortino (5Y) | -1.055 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.50% |